Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts - Wikidata - awgldk - TriplyDB

Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts

Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts

http://www.wikidata.org/entity/Q34349048

about

Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors The rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine?FGF receptors: cancer biology and therapeutics Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer Linked read sequencing resolves complex genomic rearrangements in gastric cancer metastases.Potential prognostic and diagnostic application of a novel monoclonal antibody against keratinocyte growth factor receptor.The study on newly developed McAb NJ001 specific to non-small cell lung cancer and its biological characteristics A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancer Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study.Research and clinical applications of molecular biomarkers in gastrointestinal carcinoma (Review).Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study Sprouty2 correlates with favorable prognosis of gastric adenocarcinoma via suppressing FGFR2-induced ERK phosphorylation and cancer progression.Understanding the genetic basis of gastric cancer: recent advances.Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma.Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales.Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?Approaches targeting the FGF-FGFR system: a review of the recent patent literature and associated advanced therapeutic agents.Therapeutic targeting of fibroblast growth factor receptors in gastric cancer.Emerging kinase inhibitors of the treatment of gastric cancer.A FGFR1 inhibitor patent review: progress since 2010.Roles of FGFR in oral carcinogenesis.Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression Intrahepatic cholangiocarcinoma: current management and emerging therapies.Emerging molecular therapeutic targets for cholangiocarcinoma.Fibroblast growth factor receptor 2: expression, roles, and potential as a novel molecular target for colorectal cancer.Treatment with FGFR2-IIIc monoclonal antibody suppresses weight gain and adiposity in KKAy mice.FGFR2, HER2 and cMet in gastric adenocarcinoma: detection, prognostic significance and assessment of downstream pathway activation.Prognostic relevance of FGFR2 expression in stage II/III gastric cancer with curative resection and S-1 chemotherapy.Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity

P2860

Q26764932-04756272-59E8-40CA-B4AE-100F7DAB534D Q26824969-12CA9827-B5BA-4F39-90C3-794CE17C0AAD Q26998790-0797576A-24B0-4756-A2A7-E7DDE860C3BA Q28074145-E1767317-4345-4A11-9B06-2AAD34AF464F Q28291186-9F0C40F0-50EF-4008-A499-A62B9396558E Q33733751-0A4E3BDD-40EE-4953-9DFE-979384CEAE55 Q33815218-3F1B6041-83D9-4484-8A15-2413478E7493 Q34136499-B869ECD4-898B-4E8F-B5A3-E3DA01C0F130 Q34221272-ACFB7E93-1659-4D3D-9239-227A781ABB78 Q34379582-70E3503D-143E-4030-AED4-5FA72955242C Q35713603-84A3B270-AD7B-420A-8C52-3FC25FB2F8C6 Q35881055-2A2C2A38-5FE6-4FF6-AB6E-9AF64BFCF957 Q36286390-3689FECE-8890-4BE1-86C5-06A60A4BB2C0 Q37302936-DB65EC12-7C0C-4BF6-993B-5856EE29E8C7 Q37565309-A4A14950-B53B-4AC9-94E3-CF69F4EDD09D Q37567109-7A31A95B-5C63-4142-B6A4-07470C1974E1 Q37594375-1EED175F-7A2E-4628-9E63-772905D6C877 Q37706271-A83DB7CC-09DC-49A4-93E1-73B8AACD985C Q38014496-A3FC8AB2-D066-4D31-A531-CDF7A9FC1D7E Q38074157-F9565D9E-79CF-4C30-9F1F-60776B69FF59 Q38087392-1E15F770-E5D8-4185-A6E1-23D79C1F6A0C Q38130312-505F47DC-3BF8-47CB-9695-B788FC99253E Q38212165-425F3977-2C25-4608-8BFB-E2959F5FDCFC Q38285703-89762AD8-1A08-4B99-8458-D6F31448B801 Q38497265-A7A2E87C-FCDF-4D00-A13B-E9BCB65C3E25 Q38506084-BEE759E3-8A8A-4E26-8C21-E5FE56D0CE5C Q38782612-7DA8D2CB-5EF1-4CD9-B617-4B8DB6168BAB Q38842890-13BE331E-BC18-4D14-BDE1-0329FED913D6 Q38922850-C6BC1EC3-06D9-45B6-87B6-EA3304E12BD9 Q39186928-85AB94D8-CC4C-4A55-9164-155914E0D8DB Q39227356-FA36072B-1F79-4C1E-B582-BF1D243A1630 Q42198612-BF6161A6-E955-4D11-991A-DAAE5BB4C252 Q42360017-48B7C156-1DF7-41D6-B5B0-135ACC7B2CA9 Q46815880-8344709C-16DD-4950-99BE-3144CB62800A Q49639370-5090E93C-CD5C-4720-895A-2898D993AFC3 Q56888731-88607A61-8C47-4989-8391-2BF8A41AB908

P2860

Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts

http://www.wikidata.org/entity/Q34349048

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Monoclonal antibodies to fibro ...... th of gastric tumor xenografts

@ast

Monoclonal antibodies to fibro ...... th of gastric tumor xenografts

@en

Monoclonal antibodies to fibro ...... th of gastric tumor xenografts

@nl

type

label

Monoclonal antibodies to fibro ...... th of gastric tumor xenografts

@ast

Monoclonal antibodies to fibro ...... th of gastric tumor xenografts

@en

Monoclonal antibodies to fibro ...... th of gastric tumor xenografts

@nl

prefLabel

Monoclonal antibodies to fibro ...... th of gastric tumor xenografts

@ast

Monoclonal antibodies to fibro ...... th of gastric tumor xenografts

@en

Monoclonal antibodies to fibro ...... th of gastric tumor xenografts

@nl

P1433

Q34349048-8BD7F80C-6C75-46EB-AB05-5BBD38AEB14C

P1476

Q34349048-4A49B047-1F25-4007-98D0-87EC52EE1174

P2093

Q34349048-0DFE0CE8-D6DB-4F9D-8420-AF41AA176E35

Q34349048-49D0940C-D7D5-462F-9140-DE8E0605E7EB

Q34349048-5B31342A-F149-4877-B871-7433FB2A8902

Q34349048-8CB1CBA7-5E0D-49F9-9763-4324E0BFC8AB

Q34349048-A5A082B9-E378-4855-AAB1-8C54E0ACF6FA

Q34349048-C8BB36F9-7856-483E-BE9A-01B92D93BDAF

Q34349048-D515D0B6-8976-4E6F-819D-F0A02D0DCD26

P2860

Q34349048-02CEA33E-ED11-4E87-90A4-20EA79365172

Q34349048-031DF16E-4D19-46F6-BCC9-1C690920B136

Q34349048-03AE8B4B-D17E-42FD-98D5-4198BFF99BAC

Q34349048-0AB0E7B3-7782-4E1F-ADCC-3C6A94F13698

Q34349048-0B71DAAF-BF2C-45B5-927F-1AD1A0B001CE

Q34349048-156DC040-7AFC-4D9A-A509-F592455B6EAF

Q34349048-15F76883-2251-4251-A220-62DD05B57889

Q34349048-16B25614-211B-4E13-A9E0-32F087FC5B1A

Q34349048-16CD8455-56F4-4AF4-9BEB-E310A46DE2D0

Q34349048-1C4CBEC4-E917-4807-B567-0E179E1FC99E

P304

Q34349048-62895D57-A9B4-4D14-BD9D-36BE86E4C1D2

P31

Q34349048-485107EF-9EFE-4D4C-8C4F-2CEEB0702919

P356

Q34349048-F4CC48EC-6915-4879-BFB2-C4F921A0F99A

P407

Q34349048-9C42ED24-F84C-4DB4-92AB-81C9462698A8

P433

Q34349048-3863001B-3D20-4EF3-9F8D-FFCC4B625ADD

P478

Q34349048-3DB90519-030F-479D-BB39-07504B9E57BF

P577

Q34349048-B4C36D9E-D7F4-4D30-82BB-FC7F501FD28F

P698

Q34349048-1D6363CE-C91B-4DC5-83A1-F7BEB8D58139

P921

Q34349048-A0197E08-7A54-4CDE-AE7A-82D1991152B9

Q34349048-B7B73AAB-CD4B-4B9F-9007-E9C229AA0EC2

P932

Q34349048-14927862-D03B-49C9-9935-0EF3746C4C5E

P356

1078-0432.CCR-10-0531

P1433

Clinical Cancer Research

P1476

Monoclonal antibodies to fibro ...... th of gastric tumor xenografts

@en

P2093

Hangil Park

http://www.w3.org/2001/XMLSchema#string

K Jin Kim

http://www.w3.org/2001/XMLSchema#string

Lihong Wang

http://www.w3.org/2001/XMLSchema#string

Masakazu Yashiro

http://www.w3.org/2001/XMLSchema#string

Melanie Tanphanich

http://www.w3.org/2001/XMLSchema#string

Sophea Chhim

http://www.w3.org/2001/XMLSchema#string

Wei-meng Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Receptor specificity of the fibroblast growth factor family

Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene

Fibroblast growth factors

Genome-wide association study identifies novel breast cancer susceptibility loci

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family

Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice

Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2)

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes.

P304

5750-5758

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-10-0531

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20670946

http://www.w3.org/2001/XMLSchema#string

P921

P932

2991553

http://www.w3.org/2001/XMLSchema#string